PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN by Novartis is clinical pharmacology propoxyphene is a centrally acting narcotic analgesic agent. First approved in 1989.
Drug data last refreshed 23h ago
CLINICAL PHARMACOLOGY Propoxyphene is a centrally acting narcotic analgesic agent. Equimolar doses of propoxyphene hydrochloride or napsylate provide similar plasma concentrations. Following administration of 65, 130, or 195 mg of propoxyphene hydrochloride, the bioavailability of propoxyphene is…
Worked on PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.